<DOC>
	<DOCNO>NCT01199341</DOCNO>
	<brief_summary>The primary purpose study determine whether treatment AZD1981 affect exposure Warfarin .</brief_summary>
	<brief_title>A Drug-Drug Interaction Study Study Effect AZD1981 Warfarin</brief_title>
	<detailed_description />
	<mesh_term>Warfarin</mesh_term>
	<criteria>Have body mass index 19 30 kg/m2 weight least 65 kg 100 kg Be nonsmoker exsmoker stop smoke &gt; 6 month prior screen Volunteers must willing use barrier method contraception study 3 month end participation study Volunteer infer increased sensitivity warfarin base genotype CYP2C9 VKORC1 . Any clinically significant disease disorder Any clinically relevant abnormal finding physical examination</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>Phase 1</keyword>
	<keyword>Drug-Drug interaction</keyword>
	<keyword>warfarin</keyword>
	<keyword>AZD1981</keyword>
</DOC>